Centre Technology Transfer CITTRU posted this:A new method of the stereoselective synthesis of chosen medicinesThe subject of the offer is a new method of an asymmetric reduction of prochiral ketones and imines used in the synthesis of commonly used medicines, e.g. hormonal (eg. Cincalcet), pulmonary (eg. Salbutamol) and neurological ones (eg. Rasagiline).
Guillermo Rodríguez posted this:
R&D Manager at Biótica, Bioquímica Analítica,S.L.
Technology Transfer OfficeView Profile
Yissum - Research Development Company of the Hebrew University posted this:Self-Operated App for Classification, Diagnosis, and Rehabilitation of Language Disorders (Aphasia)Self-Operated App for Classification, Diagnosis, and Rehabilitation of Language Disorders (Aphasia) Project ID : 19-2019-6710
Technology Transfer OfficeView Profile
Fundación para la Investigación Biosanitaria de Andalucía Oriental (FIBAO) posted this:Predict method of Pregnant Gestational ageDespite the great effort among all sectors of health, the rate of PD remains the "big problem" for obstetricians, neonatologists and other medical specialists, both the difficulties related to the care and complications of those born and their prognosis. long-term. Because PD, in addition to increasing perinatal morbidity and mortality, causes neurological damage and affects development in newborns, there is a great need to identify women at risk of preterm delivery and includes the mechanisms that culminate in PP. method that serves to predict, with clinical and analytical variables, the week of gestation in which delivery will occur.
Ivan Rodriguez Rosello posted this:
Licensing Manager at Universidad de Alicante
Small and Medium Enterprise
Hygea Salud y Nutrición posted this:Nutritional software which makes automatically personalized diets.Vitadieta is a system of Medical Nutrition Therapy, which makes automatically personalized diets for a wide range of goals (lose weight, healthy diet, sports nutrition, pathologies...). The system could be integrate inside a third-party software, or works online. Vitadieta offers functionalities of cross-selling oriented to franchises, recomending product and services of each franchise with the diets.
Technology Transfer Office
Cracow University of Technology posted this:The new lupeol derivative and the method of obtaining.This invention relates to a biologically active compound, the derivative of natural triterpene lupeol. This derivative is active for human skin cells, improving their proliferation process. In addition, the substance has the ability to neutralize free radicals. The described derivative can be used as an active ingredient in pharmaceutical and cosmetic preparations dedicated for damaged or burned skin, as well as in anti-aging cosmetics.
University of Vigo posted this:Pyridazin-3(2H)-one Derivatives as Selective Inhibitors of Monoamine Oxidase-B Isoform (MAO-B)The pyridazine ring is a privileged fragment found in compounds with very different pharmacological properties, such as antihypertensive, antiplatelet, anti-inflammatory, antinociceptive, antidepressant, hypoglycemic, antiinfective or anticancer agents, many of them being pyridazin-3(2H)-one derivatives. The pyridazine ring is also included in polycyclic compounds acting as MAO-B inhibitors. However, simple pyridazin-3(2H)-one derivatives have not been described so far as selective MAO-B inhibitors. The present invention provides novel pyridazin-3(2H)-one derivatives substituted at C4, C5 or C6 with several dithiocarbamate moieties that selectively inhibit the MAO-B activity and whose structure is unrelated to those currently available.
Universidad de Alicante posted this:A decision support system for melanoma diagnosis.A Spanish Research Group has developed a system to help in the recognition of a melanoma through the visual characteristics of an image of the skin lesion. This system can be used as an automated way to decide the urgency to refer a patient to the dermatologist.
Universidad de Alicante posted this:System for a customized and natural rehabilitation and interaction of disabled peopleResearchers at Institute for Computing Research of the University of Alicante have developed a multisensor system for rehabilitation and interaction of people with motor and cognitive disabilities. The system enables to perform different therapies using multiple modes of interaction (pose and gestures of the body and hands, voice, touch and gaze position) depending on the type and degree of disability. Through a training process, the system can be customized enabling the definition of patients’ own gestures for each sensor. The system is integrated with a range of applications for rehabilitation through virtual reality applications and 3D interfaces. Examples of these applications could be the realization of puzzles, mazes and writing with predictive text. The system also provides a flexible and modular framework for the development of new applications oriented to new therapies. Entities and companies interested in commercial agreement, technical assistance or technical cooperation or a combination of some of these services are sought.
Universidad de Alcalá-OTRI posted this:Detector of early allergic reactions during diagnostic challenge tests for food and drugs.GEINTRA is a research group from the Department of electronic of the University of Alcala. One of its research areas is the analysis of biomedical. The algorithm obtained allows detecting in an early stage the appearance of allergic reactions during the exposure or provocation test are made in a hospital. This system is based on the measurement of the heart rate variability. With this methodology the time of exposure to the tests is reduced therefore the stress for the patient decreases. The group is looking for companies working in the health sector to achieve technical cooperation and manufacturing agreements or commercial agreements with technical cooperation.
IDIBELL posted this:Companion diagnostic for cutaneous and uveal melanomaCompanion diagnostic for cutaneous and uveal melanoma. Our combination drug therapy for metastatic melanoma offers an alternative treatment for patients that do not have the BRAF V600 mutation or for patients resistant to Vemurafenib. Additionally, our technology can be used as a prognostic test to predict the risk of metastasis in uveal and cutaneous melanoma.
Servei de Gestió de la Innovació posted this:
Licensing Manager at Universitat Politècnica de Catalunya - UPC
Radoslaw Rudz posted this:
Licensing Manager at Centre Technology Transfer CITTRU